Overview of the Current Approach to Glomerular Disease Classification

Living reference work entry

Abstract

Classification systems of disease states are created to help stratify disease to help guide clinical evaluation and treatment and provide insights into prognosis. Glomerulonephritis is a term used to broadly characterize kidney diseases that occur as a result of immunologic and inflammatory injury to the glomeruli. There are several types of glomerular diseases and these diseases can be classified based on their clinical presentation, etiology, histology, or pathogenesis. Since the incorporation of the kidney biopsy into routine practice, histopathological classification of glomerular diseases has emerged and is now most commonly used method to characterize the different glomerular lesions identified and classify the different glomerular diseases. In this chapter, we will review the current classification systems used in clinical practice to characterize and differentiate glomerular diseases.

Keywords

Glomerulonephritis Glomerular disease Classification Kidney disease Kidney histology Nephritis Nephrotic syndrome IgA nephropathy Lupus nephritis Focal segmental glomerulosclerosis Histopathology 

References

  1. Addis T (1948) Mechanism of proteinuria. Science 108:680PubMedGoogle Scholar
  2. Akimoto T, Ito C, Saito O et al (2008) Microscopic hematuria and diabetic glomerulosclerosis – clinicopathological analysis of type 2 diabetic patients associated with overt proteinuria. Nephron Clin Pract 109:c119–c126.  https://doi.org/10.1159/000145454 CrossRefPubMedGoogle Scholar
  3. Arneil GC (1971) The nephrotic syndrome. Pediatr Clin N Am 18:547–559CrossRefGoogle Scholar
  4. Austin HA, Muenz LR, Joyce KM et al (1983) Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med 75:382–391.  https://doi.org/10.1016/0002-9343(83)90338-8 CrossRefPubMedGoogle Scholar
  5. Baqi N, Singh A, Balachandra S et al (1998) The paucity of minimal change disease in adolescents with primary nephrotic syndrome. Pediatr Nephrol 12:105–107CrossRefPubMedGoogle Scholar
  6. Beck LH, Bonegio RGB, Lambeau G et al (2009) M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephropathy. N Engl J Med 361:11–21.  https://doi.org/10.1056/NEJMoa0810457 CrossRefPubMedPubMedCentralGoogle Scholar
  7. Beniwal P, Pursnani L, Sharma S et al (2016) A clinicopathologic study of glomerular disease: a single-center, five-year retrospective study from Northwest India. Saudi J Kidney Dis Transpl 27:997–1005CrossRefPubMedGoogle Scholar
  8. Berden AE, Ferrario F, Hagen EC et al (2010) Histopathologic classification of ANCA-associated glomerulonephritis. J Am Soc Nephrol 21:1628–1636.  https://doi.org/10.1681/ASN.2010050477 CrossRefPubMedGoogle Scholar
  9. Berden AE, Jones RB, Erasmus DD et al (2012) Tubular lesions predict renal outcome in antineutrophil cytoplasmic antibody-associated glomerulonephritis after rituximab therapy. J Am Soc Nephrol 23:313–321.  https://doi.org/10.1681/ASN.2011040330 CrossRefPubMedGoogle Scholar
  10. Björneklett R, Sriskandarajah S, Bostad L (2016) Prognostic value of histologic classification of ANCA-associated glomerulonephritis. Clin J Am Soc Nephrol 11:2159–2167CrossRefPubMedGoogle Scholar
  11. Black D (1980) The story of nephrology. J R Soc Med 73:514–518PubMedPubMedCentralGoogle Scholar
  12. Brodsky SV, Satoskar A, Chen J et al (2009) Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis 54:1121–1126.  https://doi.org/10.1053/j.ajkd.2009.04.024 CrossRefPubMedGoogle Scholar
  13. Bu F, Borsa NG, Jones MB et al (2016) High-throughput genetic testing for thrombotic microangiopathies and C3 glomerulopathies. J Am Soc Nephrol 27:1245–1253CrossRefPubMedGoogle Scholar
  14. Cattran DC, Brenchley PE (2017) Membranous nephropathy: integrating basic science into improved clinical management. Kidney Int 91:566–574.  https://doi.org/10.1016/j.kint.2016.09.048 CrossRefPubMedGoogle Scholar
  15. Cattran DC, Coppo R, Cook HT et al (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534–545.  https://doi.org/10.1038/ki.2009.243 CrossRefPubMedGoogle Scholar
  16. Chavers BM, Mauer SM, Ramsay RC, Steffes MW (1994) Relationship between retinal and glomerular lesions in IDDM patients. Diabetes 43:441–446CrossRefPubMedGoogle Scholar
  17. Churg J, Ehrenreich T (1973) Membranous nephropathy. Perspect Nephrol Hypertens 1(Pt 1):443–448PubMedGoogle Scholar
  18. Coppo R, Troyanov S, Bellur S et al (2014) Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int 86:828–836.  https://doi.org/10.1038/ki.2014.63 CrossRefPubMedPubMedCentralGoogle Scholar
  19. Cordova-Sanchez BM, Mejia-Vilet JM, Morales-Buenrostro LE et al (2016) Clinical presentation and outcome prediction of clinical, serological, and histopathological classification schemes in ANCA-associated vasculitis with renal involvement. Clin Rheumatol 35:1805–1816.  https://doi.org/10.1007/s10067-016-3195-z CrossRefPubMedGoogle Scholar
  20. Cornec D, Cornec-Le Gall E, Fervenza FC, Specks U (2016) ANCA-associated vasculitis – clinical utility of using ANCA specificity to classify patients. Nat Rev Rheumatol 12:570–579.  https://doi.org/10.1038/nrrheum.2016.123 CrossRefPubMedGoogle Scholar
  21. Corwin HL, Schwartz MM, Lewis EJ (1988) The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol 8:85–89CrossRefPubMedGoogle Scholar
  22. D’Agati VD, Kaskel FJ, Falk RJ (2011) Focal segmental glomerulosclerosis. N Engl J Med 2011;365:2398–411Google Scholar
  23. D’Agati V (2003) Pathologic classification of focal segmental glomerulosclerosis. Semin Nephrol 23:117–134.  https://doi.org/10.1053/snep.2003.50012 CrossRefPubMedGoogle Scholar
  24. Fiorentino M, Bolignano D, Tesar V et al (2016) Renal biopsy in 2015 – from epidemiology to evidence-based indications. Am J Nephrol 43:1–19.  https://doi.org/10.1159/000444026 CrossRefPubMedGoogle Scholar
  25. Gesualdo L, Di Palma AM, Morrone LF et al (2004) The Italian experience of the national registry of renal biopsies. Kidney Int 66:890–894CrossRefPubMedGoogle Scholar
  26. Glassock RJ, Alvarado A, Prosek J et al (2015a) Staphylococcus-related glomerulonephritis and poststreptococcal glomerulonephritis: why defining “post” is important in understanding and treating infection-related glomerulonephritis. Am J Kidney Dis 65:826–832.  https://doi.org/10.1053/j.ajkd.2015.01.023 CrossRefPubMedGoogle Scholar
  27. Glassock RJ, Fervenza FC, Hebert L, Cameron JS (2015b) Nephrotic syndrome redux. Nephrol Dial Transplant 30:12–17.  https://doi.org/10.1093/ndt/gfu077 CrossRefPubMedGoogle Scholar
  28. Gupta K, Iskandar SS, Daeihagh P, Ratliff HL, Bleyer AJ (2008) Distribution of pathologic findings in individuals with nephrotic proteinuria according to serum albumin. Nephrol Dial Transplant 23:1595–1599CrossRefPubMedGoogle Scholar
  29. Haas M (1997) Histologic subclassification of IgA nephropathy: a clinicopathologic study of 244 cases. Am J Kidney Dis 29:829–842CrossRefPubMedGoogle Scholar
  30. Haas M, Rastaldi MP, Fervenza FC (2014) Histologic classification of glomerular diseases: clinicopathologic correlations, limitations exposed by validation studies, and suggestions for modification. Kidney Int 85:779–793.  https://doi.org/10.1038/ki.2013.375 CrossRefPubMedGoogle Scholar
  31. Haas M, Verhave JC, Liu Z-H et al (2017) A multicenter study of the predictive value of crescents in IgA nephropathy. J Am Soc Nephrol 28:691–701.  https://doi.org/10.1681/ASN.2016040433 CrossRefPubMedGoogle Scholar
  32. Hall CL, Bradley R, Kerr A et al (2004) Clinical value of renal biopsy in patients with asymptomatic microscopic hematuria with and without low-grade proteinuria. Clin Nephrol 62:267–272CrossRefPubMedGoogle Scholar
  33. Haring CM, Rietveld A, van den Brand JAJG, Berden JHM (2012) Segmental and global subclasses of class IV lupus nephritis have similar renal outcomes. J Am Soc Nephrol 23:149–154.  https://doi.org/10.1681/ASN.2011060558 CrossRefPubMedGoogle Scholar
  34. Hebert LA, Parikh S, Prosek J et al (2013) Differential diagnosis of glomerular disease: a systematic and inclusive approach. Am J Nephrol 38:253–256.  https://doi.org/10.1159/000354390 CrossRefPubMedGoogle Scholar
  35. Herrera GA, Turbat-Herrera EA (2010) Renal diseases with organized deposits an algorithmic approach to classification and clinicopathologic diagnosis. Arch Pathol Lab Med 134:512–531.  https://doi.org/10.1043/1543-2165-134.4.512 PubMedGoogle Scholar
  36. Hoxha E, Wiech T, Stahl PR et al (2016) A mechanism for cancer-associated membranous nephropathy. N Engl J Med 374:1995–1996CrossRefPubMedGoogle Scholar
  37. Jennette JC, Falk RJ, Bacon PA et al (2013) 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 65:1–11.  https://doi.org/10.1002/art.37715 CrossRefPubMedGoogle Scholar
  38. Kark RM, Pirani CL, Pollak VE et al (1958) The nephrotic syndrome in adults: a common disorder with many causes. Ann Intern Med 49:751–754CrossRefPubMedGoogle Scholar
  39. Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group (2012) KDIGO clinical practice guidelines for acute kidney injury. Kidney Int Suppl 2:1–138CrossRefGoogle Scholar
  40. Kitterer D, Gürzing K, Segerer S et al (2015) Diagnostic impact of percutaneous renal biopsy. Clin Nephrol 84:311–322.  https://doi.org/10.5414/CN108591 CrossRefPubMedGoogle Scholar
  41. Köhler H, Wandel E, Brunck B (1991) Acanthocyturia – a characteristic marker for glomerular bleeding. Kidney Int 40:115–120CrossRefPubMedGoogle Scholar
  42. Korbet SM, Genchi RM, Borok RZ, Schwartz MM (1996) The racial prevalence of glomerular lesions in nephrotic adults. Am J Kidney Dis 27:647–651CrossRefPubMedGoogle Scholar
  43. Lionaki S, Blyth ER, Hogan SL et al (2012) Classification of antineutrophil cytoplasmic autoantibody vasculitides: the role of antineutrophil cytoplasmic autoantibody specificity for myeloperoxidase or proteinase 3 in disease recognition and prognosis. Arthritis Rheum 64:3452–3462.  https://doi.org/10.1002/art.34562 CrossRefPubMedPubMedCentralGoogle Scholar
  44. Lovric S, Ashraf S, Tan W, Hildebrandt F (2016) Genetic testing in steroid-resistant nephrotic syndrome: when and how? Nephrol Dial Transplant 31:1802–1813CrossRefPubMedGoogle Scholar
  45. Lyons PA, Rayner TF, Trivedi S et al (2012) Genetically distinct subsets within ANCA-associated vasculitis. N Engl J Med 367:214–223.  https://doi.org/10.1056/NEJMoa1108735 CrossRefPubMedPubMedCentralGoogle Scholar
  46. Malvar A, Pirruccio P, Alberton V et al (2015) Original article: Histologic versus clinical remission in proliferative lupus nephritis. Nephrol Dial Transplant 32(8):1338–1344.  https://doi.org/10.1093/ndt/gfv296 CrossRefGoogle Scholar
  47. Mejia-Vilet J, Córdova-Sanchez B, Uribe-Uribe N et al (2017) Prognostic significance of renal vascular pathology in lupus nephritis. Lupus 10:1042–1050.  https://doi.org/10.1177/0961203317692419 CrossRefGoogle Scholar
  48. Müller F (1905) Morbus brightii. Verhandi d Deustsch Path Geselisch 9:64–99Google Scholar
  49. Najafi CC, Korbet SM, Lewis EJ et al (2001) Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int 59:2156–2163.  https://doi.org/10.1046/j.1523-1755.2001.0590062156.x CrossRefPubMedGoogle Scholar
  50. Nast CC (2012) Infection-related glomerulonephritis: changing demographics and outcomes. Adv Chronic Kidney Dis 19:68–75.  https://doi.org/10.1053/j.ackd.2012.02.014 CrossRefPubMedGoogle Scholar
  51. O’Shaughnessy MM, Hogan SL, Poulton CJ et al (2017) Temporal and demographic trends in glomerular disease epidemiology in the Southeastern United States, 1986–2015. Clin J Am Soc Nephrol 12(4):614–623. CJN.10871016. doi: https://doi.org/10.2215/CJN.10871016
  52. Ohisa N, Yoshida K, Matsuki R et al (2008) A comparison of urinary albumin-total protein ratio to phase-contrast microscopic examination of urine sediment for differentiating glomerular and nonglomerular bleeding. Am J Kidney Dis 52:235–241.  https://doi.org/10.1053/j.ajkd.2008.04.014 CrossRefPubMedGoogle Scholar
  53. Okpechi I, Swanepoel C, Duffield M et al (2011) Patterns of renal disease in Cape Town South Africa: a 10-year review of a single-centre renal biopsy database. Nephrol Dial Transplant 26:1853–1861CrossRefPubMedGoogle Scholar
  54. Parikh SV, Alvarado A, Malvar A, Rovin BH (2015) The kidney biopsy in lupus nephritis: past, present, and future. Semin Nephrol 35:465–477.  https://doi.org/10.1016/j.semnephrol.2015.08.008 CrossRefPubMedGoogle Scholar
  55. Polito MG, Ribeiro de Moura LA, Kirsztajn GM (2010) An overview on frequency of renal biopsy diagnosis in Brazil: clinical and pathological patterns based on 9617 native kidney biopsies. Nephrol Dial Transplant 25:490–496CrossRefPubMedGoogle Scholar
  56. Pons-Estel BA, Catoggio LJ, Cardiel MH et al (2004) The GLADEL multinational Latin American prospective inception cohort of 1,214 patients with systemic lupus erythematosus. Medicine (Baltimore) 83:1–17.  https://doi.org/10.1097/01.md.0000104742.42401.e2 CrossRefGoogle Scholar
  57. Praga M, Borstein B, Andres A et al (1991) Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition. Am J Kidney Dis 17:330–338CrossRefPubMedGoogle Scholar
  58. Richards NT, Darby S, Howie AJ et al (1994) Knowledge of renal histology alters patient management in over 40% of cases. Nephrol Dial Transplant 9:1255–1259PubMedGoogle Scholar
  59. Rivera F, López-Gómez JM, Pérez-García R, Spanish Registry of Glomerulonephritis (2004) Clinicopathologic correlations of renal pathology in Spain. Kidney Int 66:898–904.  https://doi.org/10.1111/j.1523-1755.2004.00833.x CrossRefPubMedGoogle Scholar
  60. Roberts ISD, Cook HT, Troyanov S et al (2009) The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility. Kidney Int 76:546–556.  https://doi.org/10.1038/ki.2009.168 CrossRefPubMedGoogle Scholar
  61. Rockall AG, Newman-Sanders AP, al-Kutoubi MA, Vale JA (1997) Haematuria. Postgrad Med J 73:129–136CrossRefPubMedPubMedCentralGoogle Scholar
  62. Rossert J (2001) Drug-induced acute interstitial nephritis. Kidney Int 60:804–817.  https://doi.org/10.1046/j.1523-1755.2001.060002804.x CrossRefPubMedGoogle Scholar
  63. Santin S, Bullich G, Tazon-Vega B et al (2011) Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 6:1139–1148.  https://doi.org/10.2215/CJN.05260610 CrossRefPubMedPubMedCentralGoogle Scholar
  64. Satoskar AA, Nadasdy G, Plaza JA et al (2006) Staphylococcus infection-associated glomerulonephritis mimicking IgA nephropathy. Clin J Am Soc Nephrol 1:1179–1186.  https://doi.org/10.2215/CJN.01030306 CrossRefPubMedGoogle Scholar
  65. Satoskar AA, Suleiman S, Ayoub I et al (2017) Staphylococcus infection–associated GN – spectrum of IgA staining and prevalence of ANCA in a single-center cohort. Clin J Am Soc Nephrol 12:39–49.  https://doi.org/10.2215/CJN.05070516 CrossRefPubMedGoogle Scholar
  66. Sethi S, Fervenza FC (2011) Membranoproliferative glomerulonephritis: pathogenetic heterogeneity and proposal for a new classification. Semin Nephrol 31:341–348.  https://doi.org/10.1016/j.semnephrol.2011.06.005 CrossRefPubMedGoogle Scholar
  67. Sethi S, Haas M, Markowitz GS, et al (2016) Mayo clinic/renal pathology society consensus report on pathologic classification, diagnosis, and reporting of GN. J Am Soc Nephrol 2016;27:1278–87.Google Scholar
  68. Sharma SG, Bomback AS, Radhakrishnan J et al (2013) The modern spectrum of renal biopsy findings in patients with diabetes. Clin J Am Soc Nephrol 8:1718–1724.  https://doi.org/10.2215/CJN.02510213 CrossRefPubMedPubMedCentralGoogle Scholar
  69. Soares MF, Roberts IS (2017) IgA nephropathy: an update. Curr Opin Nephrol Hypertens 26(3):165–171.  https://doi.org/10.1097/MNH.0000000000000312 CrossRefPubMedGoogle Scholar
  70. Spetie DN, Nadasdy T, Nadasdy G et al (2006) Proposed pathogenesis of idiopathic loin pain-hematuria syndrome. Am J Kidney Dis 47:419–427.  https://doi.org/10.1053/j.ajkd.2005.11.029 CrossRefPubMedGoogle Scholar
  71. Stokes MB (2014) Classification systems in renal pathology. Surg Pathol Clin 7:427–441.  https://doi.org/10.1016/j.path.2014.04.007 CrossRefPubMedGoogle Scholar
  72. Tanaka S, Ninomiya T, Katafuchi R et al (2013) Development and validation of a prediction rule using the Oxford classification in IgA nephropathy. Clin J Am Soc Nephrol 8:2082–2090.  https://doi.org/10.2215/CJN.03480413 CrossRefPubMedPubMedCentralGoogle Scholar
  73. Tervaert TWC, Mooyaart AL, Amann K et al (2010) Pathologic classification of diabetic nephropathy. J Am Soc Nephrol 21:556–563.  https://doi.org/10.1681/ASN.2010010010 CrossRefPubMedGoogle Scholar
  74. Tomas NM, Beck LH, Meyer-Schwesinger C et al (2014) Thrombospondin type-1 domain-containing 7A in idiopathic membranous nephropathy. N Engl J Med 371:2277–2287.  https://doi.org/10.1056/NEJMoa1409354 CrossRefPubMedPubMedCentralGoogle Scholar
  75. Topham PS, Harper SJ, Furness PN et al (1994) Glomerular disease as a cause of isolated microscopic haematuria. Q J Med 87:329–335PubMedGoogle Scholar
  76. Trimarchi H, Barratt J, Cattran DC et al (2017) Oxford classification of IgA nephropathy 2016. Update from the IgA nephropathy classification working group. Kidney Int 91(5):1014–1021CrossRefPubMedGoogle Scholar
  77. Vivarelli M, Massella L, Ruggiero B, Emma F (2017) Minimal change disease. Clin J Am Soc Nephrol 12:332–345.  https://doi.org/10.2215/CJN.05000516 CrossRefPubMedGoogle Scholar
  78. Walker PD, Cavallo T, Bonsib SM, Society AHC on RBG of the RP (2004) Practice guidelines for the renal biopsy. Mod Pathol 17:1555–1563.  https://doi.org/10.1038/modpathol.3800239 CrossRefPubMedGoogle Scholar
  79. Watts R, Lane S, Hanslik T et al (2007) Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis 66:222–227CrossRefPubMedGoogle Scholar
  80. Weening JJ, D’agati VD, Schwartz MM et al (2004) The classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int 65:521–530.  https://doi.org/10.1111/j.1523-1755.2004.00443.x CrossRefPubMedGoogle Scholar
  81. Wiggins RC, Alpers CE, Holzman LB et al (2014) Glomerular disease: looking beyond pathology. Clin J Am Soc Nephrol 9:1138–1140.  https://doi.org/10.2215/CJN.01450214 CrossRefPubMedPubMedCentralGoogle Scholar
  82. Wilhelmus S, Alpers CE, Cook HT et al (2015a) The revisited classification of GN in SLE at 10 years: time to re-evaluate histopathologic lesions. J Am Soc Nephrol 26:2938–2946.  https://doi.org/10.1681/ASN.2015040384 CrossRefPubMedPubMedCentralGoogle Scholar
  83. Wilhelmus S, Cook HT, Noël L-H et al (2015b) Interobserver agreement on histopathological lesions in class III or IV lupus nephritis. Clin J Am Soc Nephrol 10:47–53.  https://doi.org/10.2215/CJN.03580414 CrossRefPubMedGoogle Scholar
  84. Wu L-H, Yu F, Tan Y et al (2013) Inclusion of renal vascular lesions in the 2003 ISN/RPS system for classifying lupus nephritis improves renal outcome predictions. Kidney Int 83:715–723.  https://doi.org/10.1038/ki.2012.409 CrossRefPubMedGoogle Scholar
  85. Wyatt RJ, Julian BA (2013) IgA nephropathy. N Engl J Med 368:2402–2414.  https://doi.org/10.1056/NEJMra1206793 CrossRefPubMedGoogle Scholar
  86. Xiao X, Pickering MC, Smith RJH (2014) C3 glomerulopathy: the genetic and clinical findings in dense deposit disease and c3 glomerulonephritis. Semin Thromb Hemost 40:465–471.  https://doi.org/10.1055/s-0034-1376334 CrossRefPubMedGoogle Scholar
  87. Youn T, Trachtman H, Gauthier B (2006) Clinical spectrum of gross hematuria in pediatric patients. Clin Pediatr (Phila) 45:135–141.  https://doi.org/10.1177/000992280604500204 CrossRefGoogle Scholar
  88. Yu F, Wu L, Tan Y et al (2010) Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Kidney Int 77:820–829.  https://doi.org/10.1038/ki.2010.13 CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Wexner Medical CenterThe Ohio State UniversityColumbusUSA
  2. 2.Department of Internal Medicine, Division of NephrologyThe Ohio State University Medical CenterColumbusUSA

Personalised recommendations